Salati, Massimiliano
 Distribuzione geografica
Continente #
NA - Nord America 3.962
AS - Asia 1.956
EU - Europa 1.920
SA - Sud America 265
Continente sconosciuto - Info sul continente non disponibili 79
AF - Africa 59
OC - Oceania 2
Totale 8.243
Nazione #
US - Stati Uniti d'America 3.810
GB - Regno Unito 655
SG - Singapore 587
CN - Cina 511
IT - Italia 477
HK - Hong Kong 251
VN - Vietnam 229
BR - Brasile 193
DE - Germania 127
RU - Federazione Russa 114
SE - Svezia 111
FI - Finlandia 103
FR - Francia 72
KR - Corea 72
BD - Bangladesh 62
CA - Canada 50
IN - India 50
ID - Indonesia 44
NL - Olanda 44
IE - Irlanda 41
LT - Lituania 34
MX - Messico 30
UA - Ucraina 26
AR - Argentina 20
AT - Austria 19
PL - Polonia 19
ES - Italia 18
JP - Giappone 18
TR - Turchia 18
BG - Bulgaria 17
IL - Israele 16
IQ - Iraq 15
ZA - Sudafrica 15
EC - Ecuador 13
TT - Trinidad e Tobago 11
VE - Venezuela 11
PY - Paraguay 10
SV - El Salvador 10
AE - Emirati Arabi Uniti 8
CZ - Repubblica Ceca 8
JM - Giamaica 8
JO - Giordania 7
PH - Filippine 7
PK - Pakistan 7
UZ - Uzbekistan 7
CL - Cile 6
GP - Guadalupe 6
GT - Guatemala 6
HN - Honduras 6
KE - Kenya 6
LY - Libia 6
MY - Malesia 6
NI - Nicaragua 6
NP - Nepal 6
SC - Seychelles 6
AL - Albania 5
BE - Belgio 5
CO - Colombia 5
CR - Costa Rica 5
CW - ???statistics.table.value.countryCode.CW??? 5
DZ - Algeria 5
AZ - Azerbaigian 4
EE - Estonia 4
GE - Georgia 4
KZ - Kazakistan 4
MA - Marocco 4
PR - Porto Rico 4
RO - Romania 4
TN - Tunisia 4
BH - Bahrain 3
CY - Cipro 3
EG - Egitto 3
NG - Nigeria 3
PE - Perù 3
PT - Portogallo 3
UG - Uganda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
CH - Svizzera 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
IR - Iran 2
KH - Cambogia 2
LB - Libano 2
LK - Sri Lanka 2
RS - Serbia 2
SA - Arabia Saudita 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
AN - Antille olandesi 1
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
DM - Dominica 1
ET - Etiopia 1
Totale 8.156
Città #
Ashburn 618
Southend 516
Santa Clara 350
Singapore 344
San Jose 299
Fairfield 244
Hong Kong 244
Hefei 196
Council Bluffs 190
Chandler 168
Woodbridge 128
Houston 107
Seattle 94
New York 93
Beijing 87
Helsinki 81
Wilmington 81
London 77
Ho Chi Minh City 75
Los Angeles 75
Nyköping 75
Cambridge 72
Seoul 68
Hanoi 66
Chicago 51
Milan 44
Ann Arbor 42
Modena 41
The Dalles 39
Dublin 38
Jacksonville 36
Jakarta 36
San Diego 32
Lauterbourg 31
Moscow 30
Bologna 29
Parma 26
Salt Lake City 26
Shanghai 26
Dearborn 25
Munich 25
Rome 24
São Paulo 22
Dallas 21
Boardman 19
Buffalo 19
Bremen 18
Frankfurt am Main 18
Reggio Emilia 18
Princeton 17
Tokyo 17
Orem 16
Sofia 16
Montreal 15
Brooklyn 14
Phoenix 14
Vilnius 14
Washington 14
Kent 13
North Bergen 13
Warsaw 13
Mexico City 12
Atlanta 11
Denver 10
Düsseldorf 10
Johannesburg 10
Palermo 10
Poplar 10
Amsterdam 9
Charlotte 9
Columbus 9
Hyderabad 9
Lappeenranta 9
San Salvador 9
Des Moines 8
Dong Ket 8
Izmir 8
Cagliari 7
Eugene 7
Guangzhou 7
Naples 7
Nuremberg 7
Portsmouth 7
Tashkent 7
Toronto 7
Tripoli 7
Turku 7
Vienna 7
Asunción 6
Belo Horizonte 6
Boston 6
Brasília 6
Haiphong 6
Managua 6
Manchester 6
Newark 6
Philadelphia 6
Porto Alegre 6
Quito 6
Rio de Janeiro 6
Totale 5.560
Nome #
Epidemiological overview of Hodgkin lymphoma across the Mediterranean Basin 788
Nivolumab-Induced Impressive Response of Refractory Pulmonary Sarcomatoid Carcinoma with Brain Metastasis 359
Caratteristiche clinico-patologiche, paesaggio trascrittomico ed implicazioni terapeutiche del 5’-ectonucleotidase CD73 (NT5E) nel tumore delle vie biliari: studio BILIARY73 346
Cancer incidence, mortality, and survival in Eastern Libya: Updated report from the Benghazi Cancer Registry 339
Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study 332
Durable remission in a patient with leptomeningeal relapse of a MYC/BCL6-positive double-hit DLBCL treated with lenalidomide monotherapy 316
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer 306
Multicentre validation of an immune-inflammation-based nomogram to predict survival in western resectable gastroesophageal adenocarcinoma: The NOMOGAST 304
Statins increase pathological response in locally advanced rectal cancer treated with chemoradiation: a multicenter experience. 279
Immune-inflammatory and clinicopathologic prognostic factors in a Western cohort of resected gastric cancers (GCs) 276
Rectal cancer restaging after neoadjuvant chemoradiation: towards a down-staging system 259
A user-friendly nomogram to predict relapse-free survival (RFS) in western patients with resected gastric cancer (GC) 256
CtDNA-guided rechallenge with anti-EGFR therapy in RASwt metastatic colorectal cancer: Evidence from clinical practice 255
The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy 252
The Prognostic Role of Early Skeletal Muscle Mass Depletion in Multimodality Management of Patients with Advanced Gastric Cancer Treated with First Line Chemotherapy: A Pilot Experience from Modena Cancer Center 242
Strong impact of sarcopenia as a risk factor of survival in resected gastric cancer patients: first Italian report of a Bicentric study 234
Heavily calcified gastrointestinal stromal tumors: Pathophysiology and implications of a rare clinicopathologic entity 233
Development and Multicenter Validation of a Novel Immune-Inflammation-Based Nomogram to Predict Survival in Western Resectable Gastric and Gastroesophageal Junction Adenocarcinoma (GEA): The NOMOGAST 229
Multicentre match-paired analysis of advanced biliary cancer long-term survivors: The BILONG study 227
A MiR181/Sirtuin1 regulatory circuit modulates drug response in biliary cancers 210
IDH signalling pathway in cholangiocarcinoma: From biological rationale to therapeutic targeting 209
Successes and failures of angiogenesis blockade in gastric and gastro-esophageal junction adenocarcinoma 202
Role of poorly differentiated cluster in gastric cancer: is it a new prognosis factor? 199
The Role of Anti-Angiogenics in Pre-Treated Metastatic BRAF-Mutant Colorectal Cancer: A Pooled Analysis 172
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy 166
Suppressing, stimulating and/or inhibiting: The evolving management of HCC patient after liver transplantation 165
Early Onset Metastatic Colorectal Cancer: Current Insights and Clinical Management of a Rising Condition 162
MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside 158
Clinical Significance of Molecular Subtypes in Western Advanced Gastric Cancer: A Real-World Multicenter Experience 146
Restaging rectal cancer after neoadjuvant chemo radiotherapy: for a down-staging classification 124
Optimizing the Continuum of Care in Gastric Cancer 124
Spontaneous Regression of an Inflammatory Myofibroblastic Tumor: A Case Report and a Review of the Literature 120
Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study 117
Post-Transplant Hepatitis D Breakthrough Driven by Integrant-Derived HBsAg from an Extrahepatic HCC Metastasis 58
Liver Transplantation Following Hepatocellular Carcinoma Rupture and Long-Term Immunotherapy: A Case Report 46
The Society for Translational Medicine: Clinical practice guidelines for the postoperative management of chest tube for patients undergoing lobectomy 33
Totale 8.243
Categoria #
all - tutte 32.591
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.591


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022299 0 0 0 0 36 23 7 31 34 39 91 38
2022/2023498 55 58 31 47 53 68 8 44 75 9 19 31
2023/2024514 15 24 32 58 89 52 84 56 8 9 35 52
2024/20251.449 35 20 22 82 245 185 138 112 179 79 152 200
2025/20262.919 250 130 206 304 423 223 403 144 234 292 199 111
2026/20271.001 86 154 223 440 98 0 0 0 0 0 0 0
Totale 8.243